What is GMVDF's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for GMVDF?

P/E (TTM) is n/a and 52-week range is $0.00 to $0.03 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s GMVDF figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for GMVDF?

The company profile lists revenue (TTM) near $19M, net income (TTM) near -$2.98B, EPS (TTM) near -$4.74 when available from the market-data feed. Figures are informational and may lag live markets.

Where is G Medical Innovations Holdings Ltd based, and what identifiers does Chartloom list?

The company context section lists headquarters in Rehovot, Central(HaMerkaz), IL, 24.5M shares outstanding, ISIN KYG394621414 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

G Medical Innovations Holdings Ltd

$GMVDF

Health Care · Health Care Providers & Services

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. The company is headquartered in Rehovot, Central(Hamerkaz). The company went IPO on 2017-10-26. The firm is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. The company develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. The company also develops wireless vital signs monitoring systems.

Employees

Website

gmedinnovations.com/

IPO

2017-10-26

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

KYG394621414

Headquarters

Rehovot, Central(HaMerkaz), IL

Shares outstanding

24.5M

NAICS sector

Manufacturing

Institutional ownership

0.01%

Browse other companiesFree AI scores and summaries for more stocks